Research Article
Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy
Table 3
Table indicating the altered CKD statuses of eGFR (CKD-EPI) changes at month 12 and month 24 according to the baseline eGFR (CKD-EPI) levels.
| | eGFR (mL/min/1.73 m2) | 12 months, n (%) | Total | value | | <60 | 60–89 | ≥90 |
| Baseline n (%) | <60 | 5 (38) | 8 (62) | 0 (0) | 13 (100) | 0.057 | 60–89 | 1 (2) | 46 (72) | 17 (26) | 64 (100) | | ≥90 | 0 (0) | 14 (27) | 38 (73) | 52 (100) | | Total | | 6 (5) | 68 (52) | 55 (43) | 129 (100) | |
| | eGFR (mL/min/1.73 m2) | 24 months, n (%) | Total | value | | <60 | 60–89 | ≥90 |
| Baseline n (%) | <60 | 2 (15) | 11 (85) | 0 (0) | 13 (100) | 0.006 | 60–89 | 1 (2) | 42 (65) | 21 (33) | 64 (100) | | ≥90 | 0 (0) | 13 (25) | 39 (75) | 52 (100) | | Total | | 3 (2) | 66 (51) | 60 (47) | 129 (100) | |
|
|